Aura Biosciences, Inc.
AURA$428M
Small CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaBOSTON106 employees
Drugs in Pipeline
3
Phase 3 Programs
1
Upcoming Catalysts
2
Next Catalyst
Jun 30, 2026
6wMarket Overview
Stock performance and key metrics
AURA News
Catalyst Timeline
2 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Bel-sar | Phase 3 | Choroidal Melanoma | - | - |
Light-activated AU-011 | Phase 2 | Uveal Melanoma | - | - |
AU-011 | Phase 2 | Eye Cancer | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply